| Date | Time | Source | Headline | Symbol | Company |
| 10/20/2009 | 4:10PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/20/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2009 | 5:21PM | Dow Jones News | 2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron Consulting | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 10/19/2009 | 4:17PM | Dow Jones News | UPDATE: Galleon Holdings Include OSI Pharma, Huron Consulting | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 10/19/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2009 | 4:05PM | Dow Jones News | Galleon Holdings Include OSI Pharmaceuticals, Huron Consulting | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 10/16/2009 | 7:18AM | Marketwired | AnalystChoice.com Provides Analytical Coverage on COMS, AMLN, ERIC, CPST, ESLR and CVBF | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/13/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/09/2009 | 5:31PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/07/2009 | 6:32AM | Marketwired | RothmanResearch.com Stock Review for ETFC, COMS, AMLN, ESLR, BMRN and ISIL | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2009 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2009 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2009 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/30/2009 | 6:16AM | Dow Jones News | Novo Nordisk's Diabetes Drug Victoza Successful In Study | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 09/24/2009 | 8:05AM | Business Wire | Alkermes Announces Amylin and Lilly Will Present More than 20 Studies for Exenatide at EASD 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/24/2009 | 8:00AM | PR Newswire (US) | Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/24/2009 | 6:02AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of DRYS, COMS, ETFC, AMLN, ISIL and ARUN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/18/2009 | 4:27PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/18/2009 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/11/2009 | 6:01AM | Marketwired | TheFortuneFinancial.com Free Market Research on CDNS, ERIC, ISIL, AMLN, JDSU and FNFG | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/10/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/10/2009 | 3:33PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/08/2009 | 11:32AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/03/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/28/2009 | 6:42AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on AMLN, NVAX, PCLN, NITE, QCOM and STEC | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/24/2009 | 7:45AM | PR Newswire (US) | Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board | NASDAQ:AMLN | |
| 08/07/2009 | 4:26PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |